Conference title: International conference on Dual Diagnosis and Disorders
Theme: Integrative learning of Substance abuse and Mental Illness under Dual Diagnosis
November 12-13, 2018 Melbourne, Australia : Conference series LLC takes a great honor in announcing the commencement of International conference on Dual Diagnosis and Disorders slated on November 12-13, 2018 Melbourne, Australia .Dual Diagnosis Disorders 2018 will provide interactive sessions regarding the mental illness, substance use in Dual diagnosis . individuals who are living with a mental illness and substance abuse issue at the same time, and as a result are suffering from co-morbidity or co-occurring disorder (COD).
The conference will feature keynote presentations by top Neurologists Psychiatrists pharma, biotech, healthcare industry professionals as well as renowned experts in psychiatric field from all around the globe.
In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for Psychiatry educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of psychiatry and neurological sciences
Dual Diagnosis Disorders 2018 brought together the International blend of people from neurological pharmaceutical, biotech & medical devices companies, business entrepreneurs, pharmaceutical consultants, R&D heads and decision makers from pharmaceuticals, contract research, clinical trials, leading universities and research institutions making it the largest endeavor from Conference series. All the papers presented at this conference will be published in special issue of Journal of Dual Diagnosis: Open Access.
Conference Highlights:
• 300+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 50+ Plenary Speakers
• 20+ Exhibitors
• 14 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings


Statistics:
• The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018..

If you would like to know more information about this conference,
Contact: Regina Reth
Program Coordinator
Tel.: +650-889-4686 extn 6092
Email: [email protected]
Website: https://dualdiagnosis-disorders.neurologyconference.com/

Linked in : https://www.linkedin.com/in/regina-reth-64407315b/
Twitter : https://twitter.com/2018Dual